The Venture Codex Logo

The Venture Codex

NYBC Ventures

420 Boylston Street Suite 501, Boston, Massachusetts, 02116, United States

Overview

Accelerating innovation in blood-related fields and cellular therapies.

Founded

2021

Deals · 12mo

3

Links

WebsiteLinkedIn

Stage focus

Series B

Geographic focus

The Netherlands
United Kingdom
United States

Sector focus

—

Investment portfolio

9rounds
NAMEDATESIZE
City Therapeutics
Jun 2026Participated
$100 MSeries B
Vitestro
Mar 2026Participated
$70 MSeries B
Cellular Origins
Dec 2025Participated
$40 MSeries A
Akadeum Life Sciences
Jun 2025Participated
$20 MOther Equity
Vittoria Biotherapeutics
Nov 2024Participated
$10 MOther Equity
Vitestro
Apr 2024Led
$21 MOther Equity
Star Therapeutics
Sep 2023Participated
$90 MSeries C
Veralox Therapeutics
Jun 2023Participated
$24 MOther Equity
Thymmune Therapeutics
Mar 2023Participated
$7 MSeed
City Therapeutics
Jun 2026Participated
$100 MSeries B
Vitestro
Mar 2026Participated
$70 MSeries B
Cellular Origins
Dec 2025Participated
$40 MSeries A
Akadeum Life Sciences
Jun 2025Participated
$20 MOther Equity
Vittoria Biotherapeutics
Nov 2024Participated
$10 MOther Equity
Vitestro
Apr 2024Led
$21 MOther Equity
Star Therapeutics
Sep 2023Participated
$90 MSeries C
Veralox Therapeutics
Jun 2023Participated
$24 MOther Equity
Thymmune Therapeutics
Mar 2023Participated
$7 MSeed
9
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

NYBC Ventures: 9 funding rounds are recorded in the selected participation categories.All available history.
NYBC Ventures: 9 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed01
Series A01
Series B02
Series C+01
Other Equity13

Monthly Deal Activity

NYBC Ventures: 9 deals are recorded across 44 months.All available history.
NYBC Ventures: 9 deals are recorded across 44 months. All available history
MonthDeals
Mar '231
Apr '230
May '230
Jun '231
Jul '230
Aug '230
Sep '231
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '241
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '241
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '251
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '251
Jan '260
Feb '260
Mar '261
Apr '260
May '260
Jun '261
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

NYBC Ventures: Health & Life Sciences is the largest displayed sector by deal count (8 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

NYBC Ventures: Health & Life Sciences is the largest displayed sector by deal count (8 deals). All available history
SectorDeals
Health & Life Sciences8
Space & Frontier Tech2
Hardware & Robotics1
Manufacturing1
Data, Analytics & IT1

Deal Size Distribution

NYBC Ventures: 9 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

NYBC Ventures: 9 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M1
$10M-$25M4
$25M-$50M1
$50M-$100M3
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

NYBC Ventures: United States has the largest recorded deal count among the displayed regions (6 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

NYBC Ventures: United States has the largest recorded deal count among the displayed regions (6 deals). All available history
RegionDeals
United States6
Europe3
NYBC Ventures: 20 co-investors are shown, with Agent Capital sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

NYBC Ventures: 20 co-investors are shown, with Agent Capital sharing 2 recorded deals. All available history
Co-investorShared deals
Agent Capital2
EIC Fund2
Invest-NL2
Sofinnova Ventures2
Sonder Capital2
AN Ventures1
Arboretum Ventures1
ARCH Venture Partners1
BGF1
Casdin Capital1
Catalio Capital Management1
Cormorant Asset Management1
Cowen Healthcare Investments1
Fidelity Management & Research Company1
Genesys Capital1
Global BioAccess Fund1
Hatch Biofund1
Hatteras Venture Partners1
Highland Europe1
InterVest1

Investment Strategy

NYBC Ventures: Led accounts for 11% and participating for 89% of round participation.All available history.
NYBC Ventures: Led accounts for 11% and participating for 89% of round participation. All available history
CategoryDeals (count)Share (%)
Led111%
Participating889%
NYBC Ventures: Single-lead accounts for 0% and co-led for 100% of lead dynamics.All available history.
NYBC Ventures: Single-lead accounts for 0% and co-led for 100% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led1100%

Team

No team members found for this fund.